Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1995 Jan;86(1):88–94. doi: 10.1111/j.1349-7006.1995.tb02992.x

Establishment and Characterization of Acquired Resistance to Platinum Anticancer Drugs in Human Ovarian Carcinoma Cells

Toshiya Misawa 1, Fumitaka Kikkawa 2,✉, Osamu Maeda 2, Naoko H Obata 2, Koji Higashide 1, Nobuhiko Suganuma 2, Yutaka Tomoda 2
PMCID: PMC5920572  PMID: 7737915

Abstract

To investigate differences in resistance to cis‐diamminedichloroplatinum(II) (CDDP) and diammine (1,1‐cyclobutanecarboxylato)platinum(II) (CBDCA), and their newly developed derivative, ((—)‐(R)‐2‐aminomethylpyrrolidine (1,1‐cyclobutanedicarboxylato)platinum (II)) (DWA2114R), four types of resistant cell lines were established from a parental cell line (NOS2) of a serous cystadeno‐carcinoma of the ovary. The cross‐resistance of CDDP‐resistant cells (NOS2CR1 and NOS2CR2) to DWA2114R was slight (only 25% of the resistance to CDDP), and no cross‐resistance was observed to anticancer drugs other than the CDDP derivative, except to camptothecin (CPT‐11) in the case of NOS2CR2 cells. The cross‐resistance of CBDCA‐resistant cells (NOS2CBR) to DWA2114R was slight (only about 1/3 of the resistance to CBDCA), and no cross‐resistance was observed among anticancer drugs other than the CDDP derivative. On the other hand, DWA2114R‐resistant cells (NOS2DR) showed a high cross‐resistance to CDDP, CBDCA, etoposide (VP‐16), and CPT‐11. Intracellular accumulations of CDDP and CBDCA were markedly reduced in NOS2CR1, NOS2CR2, and NOS2CBR cells compared to those in NOS2 cells, but were reduced only slightly in NOS2DR cells. Intracellular accumulation of DWA2114R was reduced somewhat in the four types of resistant cells. Glutathione S‐transferase activity was not increased in any of the four types of resistant cells, and intracellular GSH concentration was increased only in NOS2CR2 cells (by 2.6 fold). From these results, we consider that the resistance mechanisms against CDDP and CDBCA are similar, and reduction of intracellular drug accumulations is a significant factor. Resistance to DWA2114R differed from resistance to CDDP and CBDCA in both cross‐resistance spectrum and resistance mechanism, indicating that reduction in intracellular drug accumulation is not the major resistance mechanism.

Keywords: Cisplatin, DWA2114R, Ovarian cancer, Drug resistance, Glutathione S‐transferase

Full Text

The Full Text of this article is available as a PDF (593.4 KB).

REFERENCES

  • 1. ) Sutton , G. P. , Stehman , F. B. , Einhorn , L. H. , Roth , L. M. , Blessing , J. A. and Ehrkich , C. E.Ten‐year follow up to patient receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma . J. Clin. Oncol. , 7 , 223 – 229 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Wharton , J. T. , Edwards , C. L. and Rutledge , F. N.Long‐term survival after chemotherapy for advanced epithelial ovarian carcinoma . Am. J. Obstet. Gynecol. , 148 , 997 – 1005 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Katabami , M. , Fujita , H. , Haneda , H. , Akita , H. , Kuzumaki , N. , Miyamoto , H. and Kawakami , Y.Reduced drug accumulation in a newly established human lung squamous‐carcinoma cell line resistant to cis‐diamminedichloroplatinum (II) . Biochem. Pharmacol. , 44 , 394 – 397 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Kelland , L. R. , Mistry , P. , Abel , G. , Loh , S. Y. , O'Neill , C. F. , Murrer , B. A. and Harrap , K. R.Mechanism‐related circumvention of acquired cis‐diamminedichloroplatinum (II) resistance using pairs of human ovarian carcinoma cell lines by ammine/amine platinum (IV) dicarboxylates . Cancer Res. , 52 , 3857 – 3864 ( 1992. ). [PubMed] [Google Scholar]
  • 5. ) Fram , R. J. , Wonda , B. A. , Wilson , J. M. and Robichaud , N.Characterization of acquired resistance to cis‐diamminedichloroplatinum (II) in BE human colon carcinoma cells . Cancer Res. , 50 , 72 – 77 ( 1990. ). [PubMed] [Google Scholar]
  • 6. ) Hamaguchi , K. , Godwin , A. K. , Yakushiji , M. , O'Dwyer , P. J. , Ozols , R. F. and Hamilton , T. C.Cross‐resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines . Cancer Res. , 53 , 5225 – 5232 ( 1993. ). [PubMed] [Google Scholar]
  • 7. ) Masuda , H. , Tanaka , T. , Matsuda , H. and Kusaba , I.Increased removal of DNA‐bound platinum in a human ovarian cancer cell line resistant to cis‐diamminedichloroplatinum (II) . Cancer Res. , 50 , 1863 – 1866 ( 1990. ). [PubMed] [Google Scholar]
  • 8. ) Kelland , L. R. , Mistry , P. and Abel , G.Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line . Cancer Res. , 52 , 1710 – 1716 ( 1992. ). [PubMed] [Google Scholar]
  • 9. ) Chen , G. and Zeller , W. J.Enhancement of cisplatin (DDP) antitumor activity by 3‐aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo . Cancer Chemother. Pharmacol. , 26 , 37 – 41 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Hrubisky , M. , McGown , A. T. and Fox , B. W.The role of metallothionein, glutathione S‐transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents . Biochem. Pharmacol. , 45 , 253 – 256 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Louie , K. G. , Behrens , B. C. , Kinsella , T. J. , Hamilton , T. C. , Grotzinger , K. R. , Mckoy , W. M. , Winker , M. A. and Ozols , R. F.Radiation survival parameters of anti‐neoplastic drug‐sensitive and ‐resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine . Cancer Res. , 45 , 2110 – 2115 ( 1985. ). [PubMed] [Google Scholar]
  • 12. ) Alberts , D. S. , Green , S. , Hannigan , E. V. , O'Toole , R. , Stock‐Novack , D. , Anderson , P. , Surwit , E. A. , Malvlya , V. K. , Nahhas , W. A. and Jolles , C. J.Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the South‐west Oncology Group of phase III randomised trial in stage III and IV ovarian cancer . J. Clin. Oncol. , 10 , 706 – 717 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Kjorstad , K. , Harris , A. , Bertelsen , K. , Slevin , M. , Schultz , H. , Hellman , K. , Janssens , N. , Martin , A. and Canetta , R.A multicenter phase II study of carboplatin in advanced ovarian carcinoma: final report . Ann. Oncol. , 3 , 217 – 222 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Endo , K. , Akamatu , K. , Matumoto , T. , Morikawa , K. , Koizumi , M. , Mitui , H. and Koizumi , K.Antitumor effect of three platinum complexes, (—)‐(R)‐2‐amino‐methylpyrrolidine(1,1‐cyclobutanedicarboxylato)platinum (II) monohydrate (DWA2114R), cis‐diammine(1,1‐cyclobutanedicarboxylato(II)platinum (CBDCA) and cis‐diamminedichloroplatinum(II) (CDDP), in mice . Anticancer Res. , 12 , 49 – 58 ( 1992. ). [PubMed] [Google Scholar]
  • 15. ) Kamisango , K. , Matumoto , T. , Akamatu , K. , Morikawa , K. , Tashiro , T. and Koizumi , K.Antitumor activity and cellular accumulation of a new platinum complex, (—)‐(R)‐2‐aminomethylpyrrolidine (1,1‐cyclobutanedicarboxylato) platinum (II) monohydrate, in cisplatin‐sensitive and‐resistant murine P388 leukemia cells . Jpn. J. Cancer Res. , 83 , 304 – 311 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Mizuno , K. , Furuhashi , Y. , Maeda , O. , Iwata , M. , Misawa , T. , Kawai , M. , Kano , T. and Tomoda , Y.Mitomycin C cross‐resistance induced by adriamycin in human ovarian cancer cells in vitro . Cancer Chemother. Pharmacol. , 26 , 333 – 339 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Pera , M. F. , Jr. and Harder , H. C.Analysis for platinum in biological material by flameless atomic absorption spectrometry . Clin. Chem. , 23 , 1245 – 1249 ( 1977. ). [PubMed] [Google Scholar]
  • 18. ) Tietze , F.Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissue . Anal. Biochem. , 27 , 502 – 522 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Habig , W. H. , Pabst , M. J. and Jakoby , W. B.Glutathione S‐transferases . J. Biol. Chem. , 249 , 7130 – 7139 ( 1983. ). [PubMed] [Google Scholar]
  • 20. ) Schagger , H. and von Jagow , G.Tricine‐sodium dodecyl sulfate‐polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa . Anal. Biochem. , 166 , 368 – 379 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Towbin , H. , Staehelin , T. and Gordon , J.Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications . Proc. Natl. Acad. Sci. USA , 76 , 4350 – 4354 ( 1979. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. ) Twentyman , P. R. , Wright , K. A. , Mistry , P. , Kelland , L. R. and Murrer , B. A.Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin . Cancer Res. , 52 , 5647 – 5680 ( 1992. ). [PubMed] [Google Scholar]
  • 23. ) Hill , B. T. , Shellard , S. A. , Hosking , L. K. , Dempke , W. C. , Fichtinger‐Schepman , A. M. , Tone , T. , Scanlon , K. J. and Whelan , R. D.Characterization of a cisplatin‐resistant human ovarian carcinoma cell line expressing cross‐resistance to 5‐fluorouracil but collateral sensitivity to methotrexate . Cancer Res. , 52 , 3110 – 3118 ( 1992. ). [PubMed] [Google Scholar]
  • 24. ) Kraker , A. J. and Moore , C. W.Accumulation of cis‐diamminedichloro‐platinum (II) and platinum analogues by platinum‐resistant murine leukemia cells in vitro . Cancer Res. , 48 , 9 – 13 ( 1988. ). [PubMed] [Google Scholar]
  • 25. ) Godwin , A. K. , Meister , A. , O'Dwyer , P. J. , Huang , C. S. , Hamilton , T. C. and Anderson , M. E.High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis . Proc. Natl. Acad. Sci. USA , 89 , 3070 – 3074 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Hill , B. T. , Shellard , S. A. , Hosking , L. K. , Dempke , W. C. and Fichtinger‐Shepman , A. M.Characterization of a cisplatin‐resistant human ovarian carcinoma cell line expressing cross‐resistance to 5‐fluorouracil but collateral sensitivity to methotrexate . Cancer Res. , 52 , 3110 – 3119 ( 1992. ). [PubMed] [Google Scholar]
  • 27. ) Puchalski , R. B. and Fahl , W. E.Expression of recombinant glutathione S‐transferase p, Ya, or Yb1 confers resistance to alkylating agents . Proc. Natl. Acad. Sci. USA , 87 , 2443 – 2447 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Miyazaki , M. , Kohno , K. , Saburi , Y. , Matsuo , K. , Ono , M. , Kuwano , M. , Tsuchida , S. , Sato , K. , Sakai , M. and Muramatsu , M.Drug resistance to cis‐diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S‐transferase pi gene . Biochem. Biophys. Res. Commun. , 166 , 1358 – 1364 ( 1990. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES